1Cademy - Findings about use of Remdesivir as COVID-19 intervention

Learn Before

Use of existing drugs to mitigate COVID-19

Relation

Findings about use of Remdesivir as COVID-19 intervention

Remdesivir, an antiviral drug developed by Gilead Sciences, has been evaluated in multiple clinical trials for treating COVID-19. Preliminary studies raised expectations for its efficacy, and it was granted emergency-use authorization to treat severe infections in the U.S. and Japan. Key findings on Remdesivir as a COVID-19 intervention include: early randomized trials unable to show reduced time to clinical improvement, viral clearance, or mortality; adverse health effects; study results on Remdesivir's benefits; availability constraints; global production; global clinical trial locations; and intracellular drug processing.

0

3

Updated 2026-07-11

Contributors are: